[BRIEFING.COM] The major averages continue to trade in a steady range, sitting mixed at midday.
Intel (INTC 45.37, -8.95, -16.48%) surpassed Q4 revenue and earnings expectations, reporting revenue of $13.7 billion and non-GAAP EPS of $0.15. However, the stock is plummeting following the release, as the company's Q1 guidance missed the mark across the board, projecting lower revenue, EPS, and gross margins than anticipated. With the stock trading at multi-year highs and up 120% since mid-September, Intel was already facing a difficult "priced for perfection" setup ahead of the announcement.
Capital One (COF 218.46, -16.61, -7.07%) is also on the retreat after the company delivered mixed Q4 results, beating slightly on revenue while missing earnings expectations with adjusted EPS of $3.86. Despite the revenue beat, the stock is trading sharply lower as investors react to the simultaneous announcement of a $5.15 billion acquisition of Brex and a cautious outlook on near-term expenses. With the stock previously buoyed by optimism surrounding the Discover merger, the added complexity of a second major integration and increased spending has created a challenging setup for the shares.
Meanwhile, Intuitive Surgical (ISRG 527.72, +1.91, +0.36%) is trading higher following another impressive earnings report, marking its third consecutive double-digit EPS beat. Revenue increased 18.8% yr/yr to $2.87 bln, also exceeding expectations. While ISRG does not provide formal revenue or EPS guidance, it expects worldwide da Vinci procedure growth of +13--15% in 2026, moderating from +18% growth in 2025.